Global and United States Immunotherapeutic Drugs Market Report & Forecast 2023-2028

Report ID: 1872837 | Published Date: Oct 2024 | No. of Page: 104 | Base Year: 2023 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Immunotherapeutic Drugs Revenue in Immunotherapeutic Drugs Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Immunotherapeutic Drugs Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Immunotherapeutic Drugs Market Size for the Year 2017-2028
        1.2.2 Global Immunotherapeutic Drugs Market Size for the Year 2017-2028
    1.3 Immunotherapeutic Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Immunotherapeutic Drugs in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Immunotherapeutic Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Immunotherapeutic Drugs Market Dynamics
        1.4.1 Immunotherapeutic Drugs Industry Trends
        1.4.2 Immunotherapeutic Drugs Market Drivers
        1.4.3 Immunotherapeutic Drugs Market Challenges
        1.4.4 Immunotherapeutic Drugs Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Immunotherapeutic Drugs by Type
    2.1 Immunotherapeutic Drugs Market Segment by Type
        2.1.1 Monoclonal Antibody
        2.1.2 Vaccines
        2.1.3 Checkpoint Inhibitor
        2.1.4 Interferon
    2.2 Global Immunotherapeutic Drugs Market Size by Type (2017, 2022 & 2028)
    2.3 Global Immunotherapeutic Drugs Market Size by Type (2017-2028)
    2.4 United States Immunotherapeutic Drugs Market Size by Type (2017, 2022 & 2028)
    2.5 United States Immunotherapeutic Drugs Market Size by Type (2017-2028)
3 Immunotherapeutic Drugs by Application
    3.1 Immunotherapeutic Drugs Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Clinics
        3.1.3 Other
    3.2 Global Immunotherapeutic Drugs Market Size by Application (2017, 2022 & 2028)
    3.3 Global Immunotherapeutic Drugs Market Size by Application (2017-2028)
    3.4 United States Immunotherapeutic Drugs Market Size by Application (2017, 2022 & 2028)
    3.5 United States Immunotherapeutic Drugs Market Size by Application (2017-2028)
4 Global Immunotherapeutic Drugs Competitor Landscape by Company
    4.1 Global Immunotherapeutic Drugs Market Size by Company
        4.1.1 Top Global Immunotherapeutic Drugs Companies Ranked by Revenue (2021)
        4.1.2 Global Immunotherapeutic Drugs Revenue by Player (2017-2022)
    4.2 Global Immunotherapeutic Drugs Concentration Ratio (CR)
        4.2.1 Immunotherapeutic Drugs Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Immunotherapeutic Drugs in 2021
        4.2.3 Global Immunotherapeutic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Immunotherapeutic Drugs Headquarters, Revenue in Immunotherapeutic Drugs Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Immunotherapeutic Drugs Headquarters and Area Served
        4.3.2 Global Immunotherapeutic Drugs Companies Revenue in Immunotherapeutic Drugs Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Immunotherapeutic Drugs Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Immunotherapeutic Drugs Market Size by Company
        4.5.1 Top Immunotherapeutic Drugs Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Immunotherapeutic Drugs Revenue by Players (2020, 2021 & 2022)
5 Global Immunotherapeutic Drugs Market Size by Region
    5.1 Global Immunotherapeutic Drugs Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Immunotherapeutic Drugs Market Size by Region (2017-2028)
        5.2.1 Global Immunotherapeutic Drugs Market Size by Region: 2017-2022
        5.2.2 Global Immunotherapeutic Drugs Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Immunotherapeutic Drugs Market Size YoY Growth 2017-2028
        6.1.2 North America Immunotherapeutic Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Immunotherapeutic Drugs Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Immunotherapeutic Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Immunotherapeutic Drugs Market Size YoY Growth 2017-2028
        6.3.2 Europe Immunotherapeutic Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Immunotherapeutic Drugs Market Size YoY Growth 2017-2028
        6.4.2 Latin America Immunotherapeutic Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Immunotherapeutic Drugs Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Immunotherapeutic Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Roche
        7.1.1 Roche Company Details
        7.1.2 Roche Business Overview
        7.1.3 Roche Immunotherapeutic Drugs Introduction
        7.1.4 Roche Revenue in Immunotherapeutic Drugs Business (2017-2022)
        7.1.5 Roche Recent Development
    7.2 Merck
        7.2.1 Merck Company Details
        7.2.2 Merck Business Overview
        7.2.3 Merck Immunotherapeutic Drugs Introduction
        7.2.4 Merck Revenue in Immunotherapeutic Drugs Business (2017-2022)
        7.2.5 Merck Recent Development
    7.3 Novartis
        7.3.1 Novartis Company Details
        7.3.2 Novartis Business Overview
        7.3.3 Novartis Immunotherapeutic Drugs Introduction
        7.3.4 Novartis Revenue in Immunotherapeutic Drugs Business (2017-2022)
        7.3.5 Novartis Recent Development
    7.4 Johnson & Johnson
        7.4.1 Johnson & Johnson Company Details
        7.4.2 Johnson & Johnson Business Overview
        7.4.3 Johnson & Johnson Immunotherapeutic Drugs Introduction
        7.4.4 Johnson & Johnson Revenue in Immunotherapeutic Drugs Business (2017-2022)
        7.4.5 Johnson & Johnson Recent Development
    7.5 GlaxoSmithKline
        7.5.1 GlaxoSmithKline Company Details
        7.5.2 GlaxoSmithKline Business Overview
        7.5.3 GlaxoSmithKline Immunotherapeutic Drugs Introduction
        7.5.4 GlaxoSmithKline Revenue in Immunotherapeutic Drugs Business (2017-2022)
        7.5.5 GlaxoSmithKline Recent Development
    7.6 AbbVie
        7.6.1 AbbVie Company Details
        7.6.2 AbbVie Business Overview
        7.6.3 AbbVie Immunotherapeutic Drugs Introduction
        7.6.4 AbbVie Revenue in Immunotherapeutic Drugs Business (2017-2022)
        7.6.5 AbbVie Recent Development
    7.7 ELI Lilly
        7.7.1 ELI Lilly Company Details
        7.7.2 ELI Lilly Business Overview
        7.7.3 ELI Lilly Immunotherapeutic Drugs Introduction
        7.7.4 ELI Lilly Revenue in Immunotherapeutic Drugs Business (2017-2022)
        7.7.5 ELI Lilly Recent Development
    7.8 Amgen
        7.8.1 Amgen Company Details
        7.8.2 Amgen Business Overview
        7.8.3 Amgen Immunotherapeutic Drugs Introduction
        7.8.4 Amgen Revenue in Immunotherapeutic Drugs Business (2017-2022)
        7.8.5 Amgen Recent Development
    7.9 AstraZeneca
        7.9.1 AstraZeneca Company Details
        7.9.2 AstraZeneca Business Overview
        7.9.3 AstraZeneca Immunotherapeutic Drugs Introduction
        7.9.4 AstraZeneca Revenue in Immunotherapeutic Drugs Business (2017-2022)
        7.9.5 AstraZeneca Recent Development
    7.10 Bristol-Mysers Squibb
        7.10.1 Bristol-Mysers Squibb Company Details
        7.10.2 Bristol-Mysers Squibb Business Overview
        7.10.3 Bristol-Mysers Squibb Immunotherapeutic Drugs Introduction
        7.10.4 Bristol-Mysers Squibb Revenue in Immunotherapeutic Drugs Business (2017-2022)
        7.10.5 Bristol-Mysers Squibb Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Immunotherapeutic Drugs Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Immunotherapeutic Drugs Market Trends
    Table 3. Immunotherapeutic Drugs Market Drivers
    Table 4. Immunotherapeutic Drugs Market Challenges
    Table 5. Immunotherapeutic Drugs Market Restraints
    Table 6. Global Immunotherapeutic Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Immunotherapeutic Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Immunotherapeutic Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Immunotherapeutic Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Immunotherapeutic Drugs Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Immunotherapeutic Drugs Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Immunotherapeutic Drugs Revenue Share by Player, 2017-2022
    Table 13. Global Immunotherapeutic Drugs Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Immunotherapeutic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapeutic Drugs as of 2021)
    Table 15. Top Players of Immunotherapeutic Drugs in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Immunotherapeutic Drugs Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Immunotherapeutic Drugs Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Immunotherapeutic Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Immunotherapeutic Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Immunotherapeutic Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Immunotherapeutic Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Immunotherapeutic Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Immunotherapeutic Drugs Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Immunotherapeutic Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Immunotherapeutic Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Immunotherapeutic Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Immunotherapeutic Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Immunotherapeutic Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Roche Company Details
    Table 31. Roche Business Overview
    Table 32. Roche Immunotherapeutic Drugs Product
    Table 33. Roche Revenue in Immunotherapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 34. Roche Recent Development
    Table 35. Merck Company Details
    Table 36. Merck Business Overview
    Table 37. Merck Immunotherapeutic Drugs Product
    Table 38. Merck Revenue in Immunotherapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 39. Merck Recent Development
    Table 40. Novartis Company Details
    Table 41. Novartis Business Overview
    Table 42. Novartis Immunotherapeutic Drugs Product
    Table 43. Novartis Revenue in Immunotherapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 44. Novartis Recent Development
    Table 45. Johnson & Johnson Company Details
    Table 46. Johnson & Johnson Business Overview
    Table 47. Johnson & Johnson Immunotherapeutic Drugs Product
    Table 48. Johnson & Johnson Revenue in Immunotherapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 49. Johnson & Johnson Recent Development
    Table 50. GlaxoSmithKline Company Details
    Table 51. GlaxoSmithKline Business Overview
    Table 52. GlaxoSmithKline Immunotherapeutic Drugs Product
    Table 53. GlaxoSmithKline Revenue in Immunotherapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 54. GlaxoSmithKline Recent Development
    Table 55. AbbVie Company Details
    Table 56. AbbVie Business Overview
    Table 57. AbbVie Immunotherapeutic Drugs Product
    Table 58. AbbVie Revenue in Immunotherapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 59. AbbVie Recent Development
    Table 60. ELI Lilly Company Details
    Table 61. ELI Lilly Business Overview
    Table 62. ELI Lilly Immunotherapeutic Drugs Product
    Table 63. ELI Lilly Revenue in Immunotherapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 64. ELI Lilly Recent Development
    Table 65. Amgen Company Details
    Table 66. Amgen Business Overview
    Table 67. Amgen Immunotherapeutic Drugs Product
    Table 68. Amgen Revenue in Immunotherapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 69. Amgen Recent Development
    Table 70. AstraZeneca Company Details
    Table 71. AstraZeneca Business Overview
    Table 72. AstraZeneca Immunotherapeutic Drugs Product
    Table 73. AstraZeneca Revenue in Immunotherapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 74. AstraZeneca Recent Development
    Table 75. Bristol-Mysers Squibb Company Details
    Table 76. Bristol-Mysers Squibb Business Overview
    Table 77. Bristol-Mysers Squibb Immunotherapeutic Drugs Product
    Table 78. Bristol-Mysers Squibb Revenue in Immunotherapeutic Drugs Business (2017-2022) & (US$ Million)
    Table 79. Bristol-Mysers Squibb Recent Development
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
List of Figures
    Figure 1. Immunotherapeutic Drugs Product Picture
    Figure 2. Global Immunotherapeutic Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Immunotherapeutic Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. United States Immunotherapeutic Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Immunotherapeutic Drugs Market Size 2017-2028 (US$ Million)
    Figure 6. United States Immunotherapeutic Drugs Market Share in Global 2017-2028
    Figure 7. Immunotherapeutic Drugs Report Years Considered
    Figure 8. Product Picture of Monoclonal Antibody
    Figure 9. Product Picture of Vaccines
    Figure 10. Product Picture of Checkpoint Inhibitor
    Figure 11. Product Picture of Interferon
    Figure 12. Global Immunotherapeutic Drugs Market Share by Type in 2022 & 2028
    Figure 13. Global Immunotherapeutic Drugs Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Immunotherapeutic Drugs Market Share by Type (2017-2028)
    Figure 15. United States Immunotherapeutic Drugs Market Share by Type in 2022 & 2028
    Figure 16. United States Immunotherapeutic Drugs Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Immunotherapeutic Drugs Market Share by Type (2017-2028)
    Figure 18. Product Picture of Hospitals
    Figure 19. Product Picture of Clinics
    Figure 20. Product Picture of Other
    Figure 21. Global Immunotherapeutic Drugs Market Share by Application in 2022 & 2028
    Figure 22. Global Immunotherapeutic Drugs Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Immunotherapeutic Drugs Market Share by Application (2017-2028)
    Figure 24. United States Immunotherapeutic Drugs Market Share by Application in 2022 & 2028
    Figure 25. United States Immunotherapeutic Drugs Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Immunotherapeutic Drugs Market Share by Application (2017-2028)
    Figure 27. North America Immunotherapeutic Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. U.S. Immunotherapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Immunotherapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Immunotherapeutic Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Immunotherapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Immunotherapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Immunotherapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Immunotherapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Immunotherapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Immunotherapeutic Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Immunotherapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Immunotherapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Immunotherapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Immunotherapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Immunotherapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Taiwan Immunotherapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Immunotherapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Immunotherapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Immunotherapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Philippines Immunotherapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America Immunotherapeutic Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico Immunotherapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil Immunotherapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina Immunotherapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Immunotherapeutic Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey Immunotherapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Immunotherapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. U.A.E Immunotherapeutic Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Roche Revenue Growth Rate in Immunotherapeutic Drugs Business (2017-2022)
    Figure 56. Merck Revenue Growth Rate in Immunotherapeutic Drugs Business (2017-2022)
    Figure 57. Novartis Revenue Growth Rate in Immunotherapeutic Drugs Business (2017-2022)
    Figure 58. Johnson & Johnson Revenue Growth Rate in Immunotherapeutic Drugs Business (2017-2022)
    Figure 59. GlaxoSmithKline Revenue Growth Rate in Immunotherapeutic Drugs Business (2017-2022)
    Figure 60. AbbVie Revenue Growth Rate in Immunotherapeutic Drugs Business (2017-2022)
    Figure 61. ELI Lilly Revenue Growth Rate in Immunotherapeutic Drugs Business (2017-2022)
    Figure 62. Amgen Revenue Growth Rate in Immunotherapeutic Drugs Business (2017-2022)
    Figure 63. AstraZeneca Revenue Growth Rate in Immunotherapeutic Drugs Business (2017-2022)
    Figure 64. Bristol-Mysers Squibb Revenue Growth Rate in Immunotherapeutic Drugs Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Merck
Novartis
Johnson & Johnson
GlaxoSmithKline
AbbVie
ELI Lilly
Amgen
AstraZeneca
Bristol-Mysers Squibb
Frequently Asked Questions
Immunotherapeutic Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Immunotherapeutic Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Immunotherapeutic Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Small Molecule API

Small Molecule API market is segmented by region (country), players, by Type and by Application.  ... Read More